#208S&P 500 rank

ROK — Rockwell Automation, Inc.

2-yr score: 52.8/100 (Middle 40%)Industrials14d
$438.51+2.51%
Description

Rockwell Automation, Inc., established in 1903 and headquartered in Milwaukee, Wisconsin, is a global leader in providing industrial automation and digital transformation solutions. The company's operations are segmented into three key areas: Intelligent Devices, Software & Control, and Lifecycle Services.

Score breakdownLatest quarter56.5 · Fair
Growth
59.4
Quality / Profitability
66.1
Financial health
64.2
Ratio screener
50.3
Track record: 2-yr avg 52.8 (Fair, 8 quarters ≈ 2 yrs) · long-term avg 52.0 (Fair, 40 quarters ≈ 10 yrs) · next earnings Nov 5, 2026 (in 14 days)
Valuation context (informational only — not part of the score)
Rich vs. its own history
Entry timing (informational only — not part of the score)
Neutral
Live market dataPrice updated Oct 21, 4:27 PM ET
P/E (TTM)
41.0
Yield
1.24%
RSI (14)
54.9
vs SMA20
+0.75%
vs SMA50
+1.59%
vs SMA200
+2.88%
Analyst target
$491
+11.9%
8 analysts
AI theoretical price
$450
+2.6%
as of 2026-09-13

Price chart & technical analysis

Loading chart…

AI deep-dive analysisAnalysis as of 2026-09-13 - price/technical figures below reflect that date, not live market data

As of 2026-09-13, Rockwell Automation traded at $428.39 (market cap ~$47.7B) after an Aug 4, 2026 Q3 FY26 print that beat on sales and EPS but triggered a ~4% pullback on a slightly light guidance midpoint. The stock sits 1.6% above its 200-day SMA but 4.6% below its 50-day, with RSI at 44.95 — a high-quality industrial mid-way through a cyclical recovery, trading a few points above its own 5-year average multiple.

AI sentimentNeutral

As of 2026-09-13, the market's read is balanced-but-tired: ROK is up 18.7% over six months but down 5.1% over one month and 6.7% over three, and RSI at 44.95 shows buyers have stepped back. The Q3 FY26 report (Aug 4, 2026) was genuinely strong — sales +8% YoY to $2.31B, organic +10%, diluted EPS $3.62 vs $1.23 a year earlier, enterprise operating margin +280bps to 22.3% — yet the stock fell ~4% because FY26 adjusted EPS guidance of $13.00–$13.30 (midpoint $13.15) came in below the most aggressive consensus. Adding to the caution: the Sensia JV dissolution (finalized April 1, 2026) peeled ~3pts off Q3 sales, analysts sit at a 'Hold' consensus (11 buy / 28 hold / 2 sell), and the $497.88 consensus target vs the $428.39 price implies only ~16% upside. The June 9, 2026 $1.0B buyback is a quiet support, not a sentiment driver.

Quarterly trend

This is a clear cyclical trough-to-recovery inflection, not a structural decline. Revenue fell from $2.56B in Q4 FY23 (period ending 2023-09-30) to a trough of $1.88B in Q1 FY25 (2024-12-31), then rebuilt to $2.31B in Q3 FY26 (2026-06-30). The YoY swing is the story: -20.6% (Q4 FY24) → -8.3% (Q1 FY25) → -5.8% (Q2 FY25) → +4.5% (Q3 FY25) → +13.8% (Q4 FY25) → +11.9% (Q1 FY26) → +11.8% (Q2 FY26) → +7.9% (Q3 FY26). Growth is positive and durable, though Q3 FY26's deceleration to +7.9% reflects the Sensia divestiture headwind rather than demand softening. Operating margin followed the same arc — roughly 13.7–15.6% through FY24 to 17.4–20.9% in the first three quarters of FY26 and 28.3% in Q3 FY26 (the reported figure includes items; the company's adjusted margin was 22.3%, +280bps YoY). EPS exited the trough cleanly: $1.61 (Q1 FY25) → $2.22 → $2.60 → $1.23 (Q4 FY25, distorted by a large below-the-line charge) → $2.69 → $3.10 → $3.62. The one blemish is that FY27 consensus EPS of $13.226 is essentially flat versus FY26 guidance of $13.15, suggesting the Street currently models a near-term plateau even as the operating trend improves.

Valuation assessment

Fair-to-slightly-expensive, not cheap. As of 2026-09-13, the headline TTM P/E of 40.1x is a distortion: TTM EPS of $10.714 still washes through the Q4 FY25 quarter where net income was only $138M against $458M of operating income, so the multiple overstates the earnings burden. On forward numbers the picture is more reasonable but still a premium: $428.39 divided by FY27 consensus EPS of $13.226 is ~32.4x, versus the company's own 5-year average P/E of 30.69x — roughly a 6% premium. P/S is 5.31x versus a 5-year average of 4.03x, a ~32% premium, and P/B is 13.7x with EV/EBITDA near 28.9x. PEG of 1.61 is not a bargain either. The deterministic overlay agrees, tagging the stock 'Rich vs. its own history.' You are paying up for the recovery and the margin story; you are not getting a discount.

Price vs. earnings playbook

The market is pricing in the recovery but has stopped short of extrapolating it. The ~32x forward multiple is only modestly above ROK's own history, and the $497.88 consensus target implies a wider ~16% re-rating that the tape has not yet granted. The crux is that FY27 consensus EPS ($13.226) shows almost no growth over FY26 guidance ($13.15). If that flat line is real — i.e., the recovery stalls into a plateau — the stock is fully valued at best and the current price embeds the good news. If instead those estimates are stale and the process-industry capex recovery (food, beverage, broader process verticals, currently sluggish) joins the data-center/semiconductor/warehouse engine, plus price-cost realization turns positive in Q4 as management guides, FY27 EPS could plausibly print $14–$15. The setup is therefore asymmetric in a mild way: little downside from estimate cuts if the plateau holds, real upside if the lagging verticals turn. Watch the Nov 5, 2026 FY27 guidance for which scenario is real.

Technical picture

As of 2026-09-13, the technicals read range-bound-to-mildly-corrective, not oversold. RSI of 44.95 is neutral-leaning-soft (no <30 oversold trigger). Price at $428.39 sits -0.59% versus the 20-day SMA, -4.63% versus the 50-day, and +1.60% versus the 200-day, with the previous close at $421.37 — so the stock has rolled under its short and medium averages while holding the long-term trend line. Returns: -1.25% (1wk), -5.10% (1mo), -6.74% (3mo), +18.69% (6mo). Read: a healthy six-month advance is digesting. Entry-timing implication: this is a 'wait for confirmation' zone — reclaiming the 50-day would mark the pullback's end, while a decisive break below the 200-day (around the low-$420s) would warn that the post-earnings drift has become a trend. RSI in the mid-40s offers no oversold entry edge today.

Macro factors
  • AI/data-center buildout: Rockwell is levered to electrical and cooling infrastructure plus semiconductor fab construction, with discrete automation verticals (semis, data centers, warehouse logistics) reportedly growing ~30% YoY — a genuine multi-year structural tailwind.
  • North American manufacturing reshoring is pulling automation capex onshore and supporting the order book.
  • Inflation and tariffs remain an active drag: management flagged double-digit-millions in cost headwinds in the back half of FY26 and is targeting ~250bps of price realization to keep tariff/cost impacts EPS-neutral.
  • Traditional process industries (food, beverage, broader process) are still in a soft capex cycle, keeping parts of Lifecycle Services sluggish (organic down 2–12% depending on division adjustments).
  • High beta of 1.515 makes the shares unusually sensitive to interest-rate and industrial-cycle risk; a rate or capex scare hits ROK harder than the average industrial.
Key catalysts
  • Q4 and full-year FY26 earnings on Nov 5, 2026 — the single biggest near-term event, with the FY27 guidance framework, book-to-bill/order momentum, and margin-expansion durability all on the table.
  • A turn in process-industry capex (food/beverage/process) that would broaden the recovery beyond the data-center/semiconductor/warehouse verticals.
  • The $1.0B open-market buyback announced June 9, 2026 (up to ~2% of shares) providing incremental EPS support.
  • Price-cost realization turning positive in Q4 FY26 as guided, removing the tariff/inflation drag from margins.
  • The Sensia JV divestiture headwind lapping out, cleaning up the YoY revenue comparison from FY27 onward.
Key risks
  • Valuation leaves no cushion: ~32x forward earnings, 5.31x sales (vs a 4.03x 5-year average), 13.7x book, and ~28.9x EV/EBITDA mean a guidance miss or margin slip gets punished disproportionately.
  • Cyclicality and a still-thin balance sheet: long-term debt of $2.57B, current ratio of 1.075, debt/equity of 1.03, and beta of 1.515 — a genuine capex down-cycle or rate shock would bite.
  • FY27 consensus EPS of $13.226 is essentially flat versus FY26 guidance, so the market may already be at peak near-term earnings expectations; any downgrade cycle is a multiple risk.
  • Persistent inflation and tariffs could outrun pricing, undermining the ~250bps price-realization and EPS-neutrality targets.
  • Competitive pressure in industrial automation software and controls could cap the mix-driven margin expansion bulls are underwriting.
Investment thesis

Rockwell is a genuinely good business — 54.5% gross margin, 23.8% ROE, 13.7% ROIC, a balance sheet that generates ~$1.5B of TTM free cash flow, and a cyclical recovery that is clearly real in the numbers. But the stock already reflects most of it: ~32x forward earnings and 5.3x sales sit above the company's own 5-year averages, FY27 consensus EPS is flat versus FY26 guidance, and the tape is drifting below its 50-day. This is a fairly-valued quality industrial, not a mispriced one. Neutral with a bias to add on a genuine pullback or on evidence that process-industry capex is joining the recovery.

AI theoretical price methodology

Applied a 34x forward P/E — a deliberate premium to ROK's 5-year average of 30.7x, justified by +280bps YoY margin expansion, ~8–12% post-trough revenue growth, and structural data-center/reshoring demand — to FY27 consensus EPS of $13.226, giving ~$450. That is roughly 5% above the $428.39 close on 2026-09-13 and well below the $497.88 analyst consensus, reflecting a good business that is close to, but not yet through, fair value.

AI lean: NeutralConfidence: Medium
AI review of the deterministic score
Partially Agree

The deterministic score (56.5, 'Fair Fundamentals') is not wrong so much as mistimed — it is entirely backward-looking and its trailing window straddles Rockwell's cyclical trough. Revenue YoY ran -20.6% (Q4 FY24) → -8.3% (Q1 FY25) → -5.8% → +4.5% → +13.8% (Q4 FY25) → +11.9% → +11.8% → +7.9% (Q3 FY26), and the Q4 FY25 EPS of $1.23 is a data artifact — net income of $138M against $458M of operating income — that drags TTM EPS to $10.71 and inflates the headline 40x P/E. Correcting for that, I'd nudge growth and quality up roughly 10 points, putting the business closer to 'Good' than 'Fair' fundamentals (one tier). What the score does capture and I agree with is valuation: P/S 5.31x vs 5.51x—correction—vs a 5-year 4.03x, and ~32x forward earnings vs a 5-year average of 30.7x, is a real 'rich vs. its own history' signal that caps the upside. Hence Partially Agree, not a rubber stamp and not a rejection.

AI-generated analysis for informational purposes only, not financial advice.